For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Email: alexis.jin@nera.com
vCard: Download
MA in International Economics and Finance, Brandeis University
BE, Donghua University, Shanghai.
Alexis Jin is a trusted transfer pricing, valuation, and intellectual property economist and a Chartered Financial Analyst® (CFA®) charterholder. She advises clients on transfer pricing-related subjects including transfer pricing planning, policy redesign post-restructuring and M&A, intercompany agreements, risk assessment, compliance documentation, tax policy assessment, tax audit defense, and transfer pricing dispute resolution.
Ms. Jin has been involved in the preparation and negotiation of several Advance Pricing Agreements (APA) and Mutual Agreement Procedures (MAP) with tax authorities in North America, Asia Pacific, and Europe and the design and implementation of global profit split systems supported by complete value chain analyses. She has formulated defensible arm’s length strategies in assisting clients from a variety of industries, including automotive, industrial machinery, pharmaceutical, consumer products, technology, retail, and transportation.
Ms. Jin also specializes in intellectual property-related topics such as valuation of intangible assets, transfer of IP, cost-sharing arrangements, and licensing arrangements. She has provided litigation support to pharmaceutical companies in patent infringement lawsuits and performed analyses of commercial success, lost profit damages, and reasonable royalty determinations.
Ms. Jin is a member of CFA Society of Chicago.
Mandarin
Title | Type | Author | ||
---|---|---|---|---|
Amount A vs Article 12B: One Size May Not Fit All | Published Article | Dr. Vladimir Starkov and Alexis Jin | ||
NERA Experts Respond to the Public Consultation Document of Pillar One: Amount B | Report | Dr. Harlow Higinbotham, Dr. Vladimir Starkov, and Alexis Jin | ||
How Would "Amount A" Affect US Corporate Income Tax Revenue? | Published Article | Vladimir Starkov and Alexis Jin | ||
|
Title | Date | |||
---|---|---|---|---|
Life Sciences Accounting and Reporting Congress | 10 August 2020 | |||
|